MUTATIONS OF CD79B ARE COMMON EVENT IN PRIMARY CENTRAL NERVOUS SYSTEM B-CELL LYMPHOMA PATIENTS AND ARE ASSOCIATED WITH UNFAVORABLE PROGNOSIS

被引:0
|
作者
Tateishi, Kensuke [1 ,2 ]
Narita, Yoshitaka [2 ]
Nakamura, Taishi [2 ,3 ]
Cahill, Daniel [1 ]
Kawahara, Nobutaka [3 ]
Ichimura, Koichi [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Natl Canc Ctr, Tokyo 104, Japan
[3] Yokohama City Univ, Yokohama, Kanagawa 232, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:28 / 28
页数:1
相关论文
共 50 条
  • [31] Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes
    Xie, Zucheng
    Qin, Yan
    Chen, Xinrui
    Yang, Sheng
    Yang, Jianliang
    Gui, Lin
    Liu, Peng
    He, Xiaohui
    Zhou, Shengyu
    Zhang, Changgong
    Tang, Le
    Shi, Yuankai
    TARGETED ONCOLOGY, 2024, 19 (03) : 383 - 400
  • [32] Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas
    Bhagavathi, S.
    Sharathkumar, A.
    Hunter, S.
    Sung, L.
    Kanhere, R.
    Venturina, M. D.
    Wilson, J. D.
    CLINICAL NEUROPATHOLOGY, 2008, 27 (01) : 13 - 20
  • [33] United we stand: Double targeting of CD79B and CD20 in diffuse large B-cell lymphoma
    Tarantelli, Chiara
    Bertoni, Francesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 169 - 170
  • [34] CD79B limits response of diffuse large B cell lymphoma to ibrutinib
    Kim, Joo Hyun
    Kim, Won Seog
    Ryu, Kyungju
    Kim, Seok Jin
    Park, Chaehwa
    LEUKEMIA & LYMPHOMA, 2016, 57 (06) : 1413 - 1422
  • [35] Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations
    Cao, Xin-xin
    Li, Jian
    Cai, Hao
    Zhang, Wei
    Duan, Ming-hui
    Zhou, Dao-bin
    ANNALS OF HEMATOLOGY, 2017, 96 (11) : 1867 - 1871
  • [36] Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations
    Xin-xin Cao
    Jian Li
    Hao Cai
    Wei Zhang
    Ming-hui Duan
    Dao-bin Zhou
    Annals of Hematology, 2017, 96 : 1867 - 1871
  • [37] Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders
    McCarron, KF
    Hammel, JP
    Hsi, ED
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) : 805 - 813
  • [38] Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?
    Kim, Jung A.
    Kim, Seok Jin
    Do, In-Gu
    Jin, Juyoun
    Nam, Do-Hyun
    Ko, Young Hyeh
    Kim, Kihyun
    Kim, Won Seog
    LEUKEMIA & LYMPHOMA, 2011, 52 (02) : 205 - 213
  • [39] Is Bone Marrow Biopsy Necessary for Patients with Primary Central Nervous System Large B-Cell Lymphoma?
    Lin, C. S.
    Monroe, M.
    Grier, D. D.
    Mott, R. T.
    Dunbar, E. M.
    Li, Y.
    Yachnis, A. T.
    Al-Quran, S. Z.
    MODERN PATHOLOGY, 2011, 24 : 307A - 307A
  • [40] Is Bone Marrow Biopsy Necessary for Patients with Primary Central Nervous System Large B-Cell Lymphoma?
    Lin, C. S.
    Monroe, M.
    Grier, D. D.
    Mott, R. T.
    Dunbar, E. M.
    Li, Y.
    Yachnis, A. T.
    Al-Quran, S. Z.
    LABORATORY INVESTIGATION, 2011, 91 : 307A - 307A